Compelling evidence also supports the critical role of ANXA2 in inflammatory myopathies (Probst-Cousin et al., 2004) and in inflammatory bowel disease (Tsukamoto et al., 2013). This evidence concerns the gene ANXA2 and inflammatory bowel disease.